Thursday, September 21, 2006

Northfield Laboratories, Inc. CEO a presenter

Dr. Steven A. Gould, CEO and Chairman of Northfield Laboratories, Inc., will be presenting at the UBS Global Life Sciences Conference on Tuesday, September 26, 2006, at 9:00 a.m. E.T.

Interested parties may access the live webcast of the presentation at Northfield's site. A replay of the presentation will be available three hours following the live presentation and will be archived for two weeks. Northfield's site states:

We are a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. Northfield's product, PolyHeme(R), is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types. It has a shelf life in excess of 12 months.

No comments:

Personal Blogs - Blog Top Sites